by David Kent | Jun 19, 2014
> Just four hours after landing in Vancouver for the 2014 meeting of the International Society for Stem Cell Research, I was delighted to attend the late afternoon plenary session on Cell Heterogeneity. Both John Dick and Connie Eaves – juggernauts of the Canadian...
by Sara M. Nolte | Jun 9, 2014
> I recently wrote about the dilemma many cancer stem cell (CSC) researchers face when trying to model their disease of interest in the lab. So assuming a researcher has successfully chosen their model – what happens next? Allow me to introduce to you some of the...
by Nick Dragojlovic | May 26, 2014
> In a recent post on Signals, David Kent made the case for government-funded clinical trials of autologous stem cell therapies, since the lack of proven commercialization models in this area make it difficult to attract private investment. Another way of financing...
by Stacey Johnson | May 16, 2014
. Last November, I wrote about CCRM’s new Regenerative Medicine Video Network and featured an original video with Dr. Stephen Minger, Chief Scientist, Cellular Sciences GE Healthcare Life Sciences in the UK. If you enjoyed his industry perspective and insights on...
by Holly Wobma | May 13, 2014
> I think one of the most universally embraced ideas when people gather together and pontificate about how their relatives or colleagues turned out they way they did, is that ‘people are a product of their environment’. I’m not here to make a singular stand against...
Comments